nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—Flu symptoms—Octreotide—thymus cancer	0.162	0.203	CcSEcCtD
Nateglinide—Hepatitis cholestatic—Octreotide—thymus cancer	0.0697	0.0873	CcSEcCtD
Nateglinide—Trauma—Octreotide—thymus cancer	0.059	0.0738	CcSEcCtD
Nateglinide—Gastrointestinal symptom NOS—Octreotide—thymus cancer	0.0478	0.0598	CcSEcCtD
Nateglinide—Arthropathy—Octreotide—thymus cancer	0.0309	0.0387	CcSEcCtD
Nateglinide—Urine output increased—Octreotide—thymus cancer	0.0254	0.0318	CcSEcCtD
Nateglinide—Polyuria—Octreotide—thymus cancer	0.0232	0.0291	CcSEcCtD
Nateglinide—Injury—Octreotide—thymus cancer	0.0222	0.0278	CcSEcCtD
Nateglinide—Hypoglycaemia—Octreotide—thymus cancer	0.0209	0.0261	CcSEcCtD
Nateglinide—Osteoarthritis—Octreotide—thymus cancer	0.0204	0.0255	CcSEcCtD
Nateglinide—Influenza—Octreotide—thymus cancer	0.0176	0.0221	CcSEcCtD
Nateglinide—Sweating increased—Octreotide—thymus cancer	0.0172	0.0215	CcSEcCtD
Nateglinide—Bronchitis—Octreotide—thymus cancer	0.0169	0.0212	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Octreotide—thymus cancer	0.0164	0.0205	CcSEcCtD
Nateglinide—Neuropathy peripheral—Octreotide—thymus cancer	0.0154	0.0193	CcSEcCtD
Nateglinide—Jaundice—Octreotide—thymus cancer	0.0153	0.0192	CcSEcCtD
Nateglinide—Hepatobiliary disease—Octreotide—thymus cancer	0.0149	0.0186	CcSEcCtD
Nateglinide—Oedema peripheral—Octreotide—thymus cancer	0.0139	0.0174	CcSEcCtD
Nateglinide—Immune system disorder—Octreotide—thymus cancer	0.0127	0.0159	CcSEcCtD
Nateglinide—Malnutrition—Octreotide—thymus cancer	0.0123	0.0154	CcSEcCtD
Nateglinide—Back pain—Octreotide—thymus cancer	0.0119	0.0149	CcSEcCtD
Nateglinide—Tremor—Octreotide—thymus cancer	0.0115	0.0144	CcSEcCtD
Nateglinide—Palpitations—Octreotide—thymus cancer	0.0108	0.0136	CcSEcCtD
Nateglinide—Cough—Octreotide—thymus cancer	0.0107	0.0134	CcSEcCtD
Nateglinide—Hyperhidrosis—Octreotide—thymus cancer	0.00969	0.0121	CcSEcCtD
Nateglinide—KCNJ11—hematopoietic system—thymus cancer	0.00889	0.0442	CbGeAlD
Nateglinide—Dyspepsia—Octreotide—thymus cancer	0.00882	0.011	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Octreotide—thymus cancer	0.00865	0.0108	CcSEcCtD
Nateglinide—Fatigue—Octreotide—thymus cancer	0.00864	0.0108	CcSEcCtD
Nateglinide—PPARG—neck—thymus cancer	0.0084	0.0418	CbGeAlD
Nateglinide—Gastrointestinal pain—Octreotide—thymus cancer	0.00819	0.0103	CcSEcCtD
Nateglinide—Urticaria—Octreotide—thymus cancer	0.00796	0.00996	CcSEcCtD
Nateglinide—Abdominal pain—Octreotide—thymus cancer	0.00792	0.00991	CcSEcCtD
Nateglinide—SLC16A1—hematopoietic system—thymus cancer	0.00745	0.0371	CbGeAlD
Nateglinide—Hypersensitivity—Octreotide—thymus cancer	0.00738	0.00924	CcSEcCtD
Nateglinide—Asthenia—Octreotide—thymus cancer	0.00719	0.009	CcSEcCtD
Nateglinide—SLC15A1—epithelium—thymus cancer	0.00716	0.0356	CbGeAlD
Nateglinide—Pruritus—Octreotide—thymus cancer	0.00709	0.00887	CcSEcCtD
Nateglinide—Diarrhoea—Octreotide—thymus cancer	0.00686	0.00858	CcSEcCtD
Nateglinide—SLC16A1—epithelium—thymus cancer	0.00681	0.0339	CbGeAlD
Nateglinide—ORM1—hematopoietic system—thymus cancer	0.00669	0.0333	CbGeAlD
Nateglinide—Dizziness—Octreotide—thymus cancer	0.00663	0.00829	CcSEcCtD
Nateglinide—Vomiting—Octreotide—thymus cancer	0.00637	0.00797	CcSEcCtD
Nateglinide—Rash—Octreotide—thymus cancer	0.00632	0.00791	CcSEcCtD
Nateglinide—Dermatitis—Octreotide—thymus cancer	0.00631	0.0079	CcSEcCtD
Nateglinide—KCNJ11—lymphoid tissue—thymus cancer	0.00626	0.0311	CbGeAlD
Nateglinide—PPARG—hematopoietic system—thymus cancer	0.00625	0.0311	CbGeAlD
Nateglinide—ABCC8—pituitary gland—thymus cancer	0.00607	0.0302	CbGeAlD
Nateglinide—Nausea—Octreotide—thymus cancer	0.00595	0.00745	CcSEcCtD
Nateglinide—PPARG—epithelium—thymus cancer	0.00571	0.0284	CbGeAlD
Nateglinide—KCNJ11—thyroid gland—thymus cancer	0.00568	0.0283	CbGeAlD
Nateglinide—ABCC4—hematopoietic system—thymus cancer	0.00568	0.0282	CbGeAlD
Nateglinide—SLC16A1—cardiac atrium—thymus cancer	0.00566	0.0281	CbGeAlD
Nateglinide—SLC16A1—pituitary gland—thymus cancer	0.00553	0.0275	CbGeAlD
Nateglinide—ABCC8—thyroid gland—thymus cancer	0.00524	0.026	CbGeAlD
Nateglinide—SLC16A1—thyroid gland—thymus cancer	0.00476	0.0237	CbGeAlD
Nateglinide—PPARG—lymphoid tissue—thymus cancer	0.0044	0.0219	CbGeAlD
Nateglinide—SLC16A1—lung—thymus cancer	0.00433	0.0215	CbGeAlD
Nateglinide—ORM1—bone marrow—thymus cancer	0.00429	0.0213	CbGeAlD
Nateglinide—PPARG—bone marrow—thymus cancer	0.00401	0.0199	CbGeAlD
Nateglinide—PPARG—thyroid gland—thymus cancer	0.004	0.0199	CbGeAlD
Nateglinide—ORM1—lung—thymus cancer	0.00388	0.0193	CbGeAlD
Nateglinide—CYP3A5—hematopoietic system—thymus cancer	0.00372	0.0185	CbGeAlD
Nateglinide—CYP2C9—hematopoietic system—thymus cancer	0.00366	0.0182	CbGeAlD
Nateglinide—ABCC4—bone marrow—thymus cancer	0.00364	0.0181	CbGeAlD
Nateglinide—PPARG—lung—thymus cancer	0.00363	0.0181	CbGeAlD
Nateglinide—SLC15A2—pituitary gland—thymus cancer	0.00363	0.0181	CbGeAlD
Nateglinide—ABCC4—thyroid gland—thymus cancer	0.00363	0.0181	CbGeAlD
Nateglinide—KCNJ11—lymph node—thymus cancer	0.00353	0.0176	CbGeAlD
Nateglinide—PTGS1—hematopoietic system—thymus cancer	0.00334	0.0166	CbGeAlD
Nateglinide—ABCC4—lung—thymus cancer	0.0033	0.0164	CbGeAlD
Nateglinide—SLC15A2—thyroid gland—thymus cancer	0.00313	0.0156	CbGeAlD
Nateglinide—PTGS1—epithelium—thymus cancer	0.00305	0.0152	CbGeAlD
Nateglinide—SLC16A1—lymph node—thymus cancer	0.00296	0.0147	CbGeAlD
Nateglinide—SLC15A2—lung—thymus cancer	0.00284	0.0141	CbGeAlD
Nateglinide—CYP3A4—hematopoietic system—thymus cancer	0.00279	0.0139	CbGeAlD
Nateglinide—CYP2D6—hematopoietic system—thymus cancer	0.00275	0.0137	CbGeAlD
Nateglinide—ORM1—lymph node—thymus cancer	0.00266	0.0132	CbGeAlD
Nateglinide—PTGS1—cardiac atrium—thymus cancer	0.00254	0.0126	CbGeAlD
Nateglinide—PPARG—lymph node—thymus cancer	0.00248	0.0124	CbGeAlD
Nateglinide—PTGS1—pituitary gland—thymus cancer	0.00248	0.0123	CbGeAlD
Nateglinide—ALB—lymph node—thymus cancer	0.00233	0.0116	CbGeAlD
Nateglinide—ABCC4—lymph node—thymus cancer	0.00225	0.0112	CbGeAlD
Nateglinide—CYP3A5—lung—thymus cancer	0.00216	0.0107	CbGeAlD
Nateglinide—PTGS1—thyroid gland—thymus cancer	0.00214	0.0106	CbGeAlD
Nateglinide—SLC15A2—lymph node—thymus cancer	0.00194	0.00967	CbGeAlD
Nateglinide—PTGS1—lung—thymus cancer	0.00194	0.00966	CbGeAlD
Nateglinide—PTGS1—lymph node—thymus cancer	0.00133	0.0066	CbGeAlD
